5:48 PM
 | 
Mar 31, 2010
 |  BC Extra  |  Company News

FDA panel to discuss motavizumab

FDA's Antiviral Drugs Advisory Committee will meet on June 2 to discuss a BLA from MedImmune LLC to prevent serious respiratory...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >